Use of Ceftazidime-avibactam for the Treatment of Extensively drug-resistant or Pan drug-resistant Klebsiella pneumoniae in Neonates and Children <5 Years of Age. Επικοινωνία Submitted by Εμμανουήλ Ροηλίδης on Παρ, 11/13/2020 - 09:33
